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Abstract
Biosurfactants are amphipathic, surface-active molecules of microbial origin which accumulate at
interfaces reducing interfacial tension and leading to the formation of aggregated micellular structures
in solution. Some biosurfactants have been reported to have antimicrobial properties, the ability to
prevent adhesion and to disrupt biofilm formation. We investigated antimicrobial properties and
biofilm disruption using sophorolipids at different concentrations. Growth of Gram negative
Cupriavidus necator ATCC 17699 and Gram positive Bacillus subtilis BBK006 were inhibited by
sophorolipids at concentrations of 5% v/v with a bactericidal effect. Sophorolipids (5% v/v) were also
able to disrupt biofilms formed by single and mixed cultures of B. subtilis BBK006 and Staphylococcus
aureus ATCC 9144 under static and flow conditions, as was observed by scanning electron microscopy.
The results indicated that sophorolipids may be promising compounds for use in biomedical application
as adjuvants to other antimicrobial against some pathogens through inhibition of growth and/or biofilm
disruption.Introduction
Biosurfactants are amphiphilic compounds produced on living
surfaces, mostly on microbial cells or excreted extracellular hy-
drophobic and hydrophilic moieties, with the ability to accumu-
late and partition between fluid phases, thus reducing surface and
interfacial tension at the surface and interface, respectively [1].
Surfactants are widely used in industrial, agricultural, food, cos-
metic and pharmaceutical applications; however the majority of
surfactants are derived from petro- or oleochemicals and have the
potential to cause environmental toxicology problems due to the
recalcitrant and persistent nature of these substances [2].
The advantages associated with the use of microbially produced
biosurfactants over their chemical counterparts include; lowerCorresponding author. Tel.: +44 0 161 306 2684. Dı´az De Rienzo, M.A.
(mayri.diazderienzo@manchester.ac.uk, mayriales@gmail.com)
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720 toxicity, higher biodegradability, a wider range of effectiveness
at different environmental conditions such as pH, temperature
and high ionic strength, in addition to biocompatibility. These
advantages allow applications of biosurfactants in cosmetic, phar-
maceutical and food additives industries [3]. Biosurfactants are
classified according to their chemical structure and their microbial
origin. The main classes of biosurfactants are glycolipids, phos-
pholipids, polymeric compounds and lipopeptides. In this work
we focus on Sophorolipids (SL), a type of glycolipid. Sophorolipids
are mainly produced by yeasts such as Candida bombicola and are
composed of a dimeric sugar linked by a glycosidic bond to a
hydroxyl fatty acid [4]. The fatty acid structure and carbon chain
length may vary depending on the carbon source used to produce a
given sophorolipid.
Biosurfactants have long been reported as molecules with po-
tential applications in environmental and biomedical related areashttp://dx.doi.org/10.1016/j.nbt.2015.02.009
1871-6784/ 2015 Elsevier B.V. All rights reserved.
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tants in healthcare associated infections [8] and in particular the
rapid advances in biofilm inhibition, control or disruption involv-
ing their use. Previous studies have shown that adsorption of
biosurfactants to a solid surface can modify its hydrophobicity,
affecting the adhesion process and consequently biofilm forma-
tion [4]. Most studies regarding anti-adhesive properties of bio-
surfactants were carried out using pure cultures of microorganisms
and in the absence of culture medium. However it is known that
mixed cultures are predominantly found in biofilms and that the
presence of nutrients can affect the adhesion of single and mixed
cultures cells [9]. In this work we tested the ability of SL to
compromise cell membranes and inhibit growth of Gram positive
Bacillus subtilis BBK006 and Gram negative Cupriavidus necator
ATCC 17699 bacteria. We also studied the disruption of biofilm
formation in B. subtilis BBK006, as a single culture as well as in
mixed cultures of Staphylococcus aureus ATCC 9144 and B. subtilis
BBK006, to evaluate possible potential use in the health care
industry.
Materials and methods
Microorganisms and media
Candida bombicola ATCC 22214 was stored in nutrient broth with
20% glycerol at 80 8C. The standard medium for the production
of sophorolipids was glucose/yeast extract/urea (GYU) medium
(10% w/v glucose, 1% w/v yeast extract, 0.1% w/v urea). The
fermentation medium contained the same growth medium, with
rapeseed oil, as a second carbon source, being fed at regular
intervals to induce sophorolipid production. For the antimicrobial
assays S. aureus ATCC 9144, C. necator ATCC 17699 and B. subtilis
BBK006 were stored in nutrient broth plus 20% glycerol at 80 8C,
and used when needed.
Culture conditions
C. necator ATCC 17699, B. subtilis BBK006 and S. aureus ATCC 9144
grown on nutrient agar slants and incubated for 24 h at 30 8C were
used to obtain a bacterial suspension, with the optical density
(570 nm) adjusted to give 107 CFU/ml for each of the strains used.
Production of sophorolipids
A crude SL (S1) mixture was obtained as the settled product from
fed batch cultivation of C. bombicola ATCC 22214, operated with-
out the use of antifoam, according to Shah et al. [10], feeding
glucose and rapeseed oil rather than waste frying oil. The dry
matter content of the crude mixture sophorolipid was adjusted to
45% v/v and contained a mixture of acidic and lactonic congeners
of sophorolipids (data not shown). Residual fatty acids were less
than 1% of the total dry sophorolipid mass. As a comparison
commercially available SL (S2) were used as obtained from Soli-
ance (Reims, France) under the brand name Sopholiance, the main
difference between this and the crude S1 mixture being the lack of
C18:1 lactonic form and the presence of mainly acidic sophoro-
lipids (data not shown).
Determination of the minimum inhibitory concentration (MIC) of
sophorolipids
One millilitre of each culture (adjusted to give 107 CFU/ml) was
inoculated into a 250 ml Erlenmeyer flask containing 50 ml of LBbroth, following which a 100 ml sample of each diluted culture was
dispensed (eight replicates) to fill a 96 well Oxoplate OP96C1 for
antimicrobial assays, where S1 and S2 were applied at 5% v/v.
OxoPlate OP96C (PreSens, Regensburg, Germany) contains ox-
ygen-sensitive particles PSLi-Pt-1 (Opto-Sense, Wo¨rth, Germany),
which consist of small polystyrene particles. The sensor has a
thickness of about 10 mm and is fixed at the bottom of each well
of a 96-flat bottom-well plate (Greiner, Frickenhausen, Germany).
The oxygen concentration in each well was measured for 21 h at
20 min intervals. Fluorescence of each well was measured in dual
kinetic mode (BMG Labtech GmbH, Germany). Filter pair 1 (544/
650 nm) detects fluorescence of the indicator dye. The second
filter pair (544/590 nm) measures fluorescence of the reference
dye.
All experiments were repeated on independent days. Oxygen
concentration as percentage air saturation was calculated for each
well by using the following equation:
pO2 ¼
k0=IRð Þ  1ð Þ
k0=IRð Þ  1ð Þ  100 (1)
where R is the fluorescence intensity ratio at the oxygen concen-
tration [O2]. A two-point calibration at [O2] 0 and at [O2] = [O2]*,
where [O2]* is the saturation concentration, is sufficient. The
Intensity ratios IR were calculated for each individual well by
dividing the intensity of the indicator dye by the intensity of
the reference dye. The constant k0 is defined as the mean of the IR’s
of at least four wells filled with calibration 0. Analogously, k100 is
defined as the mean of the IR’s of at least four wells filled with cal
100.
MIC values were determined by measuring the OD at 570 nm
and comparing to those cultures where biosurfactant was added.
All the biosurfactants were added from time 0 (min) to evaluate
inhibition in vivo.
Growth and determination of the viability/disruption of biofilms
on coverslips
C. necator ATCC 17699 and B. subtilis BBK006 were grown over-
night and diluted 100-fold with nutrient broth 50% w/v, following
which 2 ml samples were dispensed in triplicate to fill a 12 well
plate, with biofilms formed on sterile, glass coverslips
(18 mm  18 mm) which were put into the 12 well plates (verti-
cally) and were incubated at 30 8C for 48 h. After this period the
plates were washed three times and the biosurfactant treatment
was applied with three replicates, for a period of 30 min (at
200 rpm). Positive and negative controls were added, using MES
(2-(N-morpholino) ethanesulfonic acid) and PBS buffer. Biofilms
were then stained with Syto19 and the structure was observed
with a fluorescence microscope at 40X magnification.
In vitro biofilm formation using an eight well chamber
An overnight culture of S. aureus ATCC 9144, B. subtilis BBK006
was adjusted to OD490 0.65 and was diluted 1:6 and incubated at
30 8C with 5% CO2 for approximately 3 h in order to reach the
mid-log phase. Once the mid-log phase was reached, the cells were
diluted 1:2500 in fresh nutrient broth and 200 ml were placed in
each well and incubated for 24 h with a change of medium every
12 h to maintain bacterial viability. To visualize the biofilms the
medium was aspirated and the resident biofilm was washed twicewww.elsevier.com/locate/nbt 721
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FIGURE 1
Oxygen consumption of Cupriavidus necator ATCC 17699 and Bacillus subtilis
BBK006 treated with different sophorolipid biosurfactants. (A) Cells of C.
necator ATCC 17699 (&) and B. subtilis BBK006 (*) in absence of treatment.
(B) Cells of C. necator ATCC 17699 in presence of sophorolipids S1 (~) and
sophorolipids S2 (!) and B. subtilis BBK006 treated with S1 (&) and S2 (*).
Treatment concentrations were 5% v/v.
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BacLight Live/Dead stain in each well. The disruption of the
biofilms was analysed using SEM, where the cells are dehydrated
in graded alcohols (50%, 65%, 80%, 95% and 100%) and after the
final dehydratation step ethanol is replaced with hexamethyldi-
silazane (HMDS) in ratios of (1:1), (1:2), (1:3) and 100%, after
which period the samples were left overnight for the solvent to
evaporate [11] and subsequently the biofilms were observed under
SEM.
Results
Effect of MIC of sophorolipids on planktonic cells of Cupriavidus
necator ATCC 17699 and Bacillus subtilis BBK006
Surfactants of both biological and chemical origin are usually
characterized by the formation of aggregated structures such as
micelles, their critical micelle concentration (CMC) and their
foaming and detergent abilities [12–14]. The Minimum Inhibitory
Concentration (MIC) is the lowest concentration of a compound
that inhibits bacterial growth. Lang and co-workers [15] reported
some biosurfactant antimicrobial activity towards B. subtilis, S.
epidermis and P. acnes at low MIC concentrations (<1.6 mM). Fig. 1
shows the antimicrobial effect of sophorolipids at concentrations
higher than 5% (v/v) during the first 3 h of growth cells of C.
necator ATCC 17699 and B. subtilis BBK006, (higher than those
required to inhibit the grown of other Gram positive and Gram
negative bacterial cells reported earlier [15,16]). However there is a
resistance shown by the cells after approximately 3 h of time
indicating a possible bacteriostatic effect of sophorolipids on C.
necator ATCC 17699 and B. subtilis BBK006, as non-pathogenic
models of study.
Biofilm formation by Bacillus subtilis BBK006 on glass coverslips:
‘‘Static conditions’’
The behaviour of planktonic cells and organized structures (bio-
films) is different when they face stressful environmental condi-
tions. The study model selected for this study was B. subtilis
BBK006, due to the inability of C. necator ATCC 17699 to develop
stable biofilms. B. subtilis biofilms were evaluated microscopically
after 48 h of incubation. Fluorescence microscopy examination
of cells attached to coverslips and stained with Syto19 showed
the presence of individual bacteria, small clusters of cells (micro-
colonies), and extended areas of the glass surface covered with
large numbers of microcolonies of active cells (Fig. 2A). B. subtilis
BBK006 was able to form biofilms like those observed for other
Pseudomonas aeruginosa, Staphylococcus epidermidis strains [17].
The biofilm formed was treated with sophorolipid sample S1
(which was selected as no significant differences were observed
to S2 sample on planktonic cells). In agreement with previous
studies [18,19] were are able to confirm here that B. subtilis
BBK006 biofilm cells are sensitive to some extent to sophorolipids
(S1) which was seen by the reduction of number of active cells
upon exposure and the appearance of some inactive reddish-
brown fluorescing cells (Fig. 2B). The results of the present study
indicate that sophorolipids have the potential to be used for
biofilm disruption and removal. This is in agreement with the
data shown by Shah et al. [4], who reported sophorolipids having
significant antibacterial activities especially against Gram posi-
tive bacteria.722 www.elsevier.com/locate/nbtEffect of S1 on pre-formed biofilms by Bacillus subtilis BBK006
and mixed cultures within the eight well chamber: ‘‘Flow
conditions’’.
In this experiment, sophorolipids at 5% v/v induced disruption on
mature maximal biofilms of B. subtilis BBK006 and a mixed culture
of B. subtilis BBK006 and S. aureus ATCC 9144. The untreated cells
as well as those treated with S1 (5% v/v) were examined by SEM to
visualize the disruptive effect of sophorolipids on the biofilms
(Fig. 3). The SEM photomicrographs of the control (Fig. 3A, C and
E) and treated (Fig. 3B, D and F) biofilms show the changes in cell
morphology. In the control the cells form different layers of
growth and the extracellular polymeric substance (EPS) are visible
(Fig. 3E). After treatment with sophorolipid only monolayers of
cells are observed and there is a visible loss of the EPS and a release
of the cytoplasmic content (Fig. 3F), this effect is also supported by
results reported by Kim et al. [20] and Dengle-Pulate et al. [21]
where B. subtilis cells surfaces (after treatment) were not only
distributed in monolayers but also disrupted with the outpouring
of their cytoplasmic contents, indicating that SL causes the release
of an intracellular enzyme malate dehydrogenase that interacts
with SL increasing the permeability.
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FIGURE 2
Biofilm formation by Bacillus subtilis BBK006 on coverslips. Cells were stained
with Syto9W and observed using a fluorescence microscope at 40. (A) B.
subtilis BBK006 biofilms after 48 h as a control. (B) After 30 min treatment in
the presence of Sophorolipids 5% v/v on 48 h preformed biofilms. The scale
bar represents 10 mm.
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Biosurfactants are amphiphilic compounds produced by micro-
organisms that reduce surface and interfacial tension. They have
been recognized for some time in potential applications in a wide
range of industries including agriculture, food, cosmetic, pharma-
ceutical and petroleum industries [6]. The surface and interfacial
tension reducing properties of surfactants provide excellent deter-
gency, emulsification, foaming and dispersing traits, making them
some of the most versatile products in chemical processes [22]. The
current hypothesis is that surface-active molecules like biosurfac-
tants play a major role in the development and maintenance of
biofilms, partly through the maintenance of water channels
through the biofilm which enhance nutrient movement and
gaseous exchange which leads to the dissociation of parts of the
biofilm into planktonic mobile forms [5]. Several strands of re-
search have demonstrated that under certain testing conditions,biosurfactants can be more effective than many traditional biofilm
inhibition and or disruption strategies [23].
Recently studies [4,5,24] reported the use of biosurfactants as
antimicrobial molecules, however due to the differences between
planktonic and biofilm physiologies affected by these kind of
compounds, this work aimed to evaluating the impact of sophor-
olipids on cells present in both forms/environments, a behavioural
variation that so far seems inconsequential. Standard bacterial
inhibition tests are almost exclusively based on planktonic bacte-
rial physiology and not the biofilm physiology, even though these
conditions are not readily observed in the natural environment.
The standard planktonic bacterial physiology is typically exempli-
fied by free-living single bacteria with optimal nutrition, gas
exchange and agitation (typically 250 rpm) [24,25]. In contrast,
the biofilm physiology has multicellular differentiation, multicel-
lular communication, internal architecture and rudimentary fluid
transport systems [26,27]. Shah et al. [4] reported on the antibac-
terial activity of SLs in various carbohydrate-containing media
against a selection of Gram-positive and Gram-negative bacteria,
in our study we selected C. necator ATCC 17699 and B. subtilis
BBK006 as model microorganisms.
C. necator was selected as suitable Gram-negative versatile PHB-
producing bacterium extensively studied and commonly used for
its ability to accumulate up to 90% of its dry weight as PHB, the
first discovered PHA [28,29]. The extraction of PHAs using organic
solvents is the most common used technique [30], however there
is a need for using green and cheap technologies to recover
polyhydroxyalkanoates (PHAs) from microbial biomass for the
development of a reliable and sustainable production chain
[31]. The importance of the use of sophorolipids is thought to
be as a novel molecule proposed to extract PHAs from C. necator.
This however has to be further investigated.
B. subtilis on the other hand was selected as one of the most
studied Gram-positive bacteria in terms of the elucidation of the
genes, proteins, and molecular mechanisms involved in biofilm
formation. However we note that among Gram-positive bacteria,
the molecular mechanisms of biofilm formation appear to be
species-specific. Several systems are in use to quantify bacterial
growth in the presence or absence of these compounds and to
study planktonic behaviour of diverse populations of cells [5]. Here
we used a fluorescence assay system, called Oxoplates1, that
quantifies the oxygen concentration in the growth medium to
evaluate the effect of S1 and S2 on planktonic cells of C. necator
ATCC 17699 and B. subtilis BBK006. Using this system a minimum
number of cells were required to consume a threshold amount of
oxygen before they were detected in the system. All the results
presented in Fig. 1 are beyond this threshold (high inoculum
density), consequently consumption of oxygen was detected im-
mediately and the growth medium was essentially free of oxygen
after 2 h, in absence of treatment (Fig. 1A).
In the presence of sophorolipids at 5% v/v we detected similar
kinetics of bacterial growth inhibition for S1 and S2, where after
addition of the treatment the oxygen concentration increased
(Fig. 1B). This increase is attributable to the enhanced diffusion
of atmospheric oxygen into the wells after cell death, which is an
indication that we might be dealing with a bactericidal com-
pound. The mechanism for bioactivity of biosurfactants is sug-
gested to be associated with their intercalation into target cellwww.elsevier.com/locate/nbt 723
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FIGURE 3
Scanning electron micrographs showing attachment and biofilm formation by Bacillus subtilis BBK006 (A) and and a mixed culture between B. subtilis BBK006
and Staphylococcus aureus ATCC 9144 (C) and (E) with an expose of the EPS substance encapsulating the cells (arrows) and cells of B. subtilis BBK006 (B) and a
mixed culture of B. subtilis BBK006 and S. aureus ATCC 9144 (D) and (F) treated with S1 5% v/v showing cells disruption with outporing of cytoplasmatic
724 www.elsevier.com/locate/nbt
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effective against C. necator ATCC 17699 and B. subtilis BBK006,
and that at the concentration tested sophorolipids are comparable
to conventional antimicrobials used in agriculture and healthcare
industry [32], as well as synthetic surfactant as SDS for the extrac-
tion of PHA [33].
The deposition of microorganisms on solid surfaces, and subse-
quent biofilm formation is a phenomenon that happens naturally
and is part of microorganisms’ strategy to protect themselves from
external toxic factors [34]. The inability to form biofilms by C.
necator ATCC 17699 led us to focus on the formation of biofilms by
B. subtilis BBK006 as a model of a Gram positive bacteria (most of
them can cause various infections including hospital-acquired
infections), which is best known for its ability to become compe-
tent and undergo sporulation in response to starvation and high
population densities [35]. These biofilms are difficult to treat due
to their resistance to antibiotics and biocides [4,36]. Interestingly
the surfactant produced by Streptococcus thermophilus has also been
shown to be effective industrially for the control of fouling of heat
exchanger plates in pasteurizers [36].
In this study biofilm formation of B. subtilis BBK006 was evalu-
ated microscopically after 48 h of incubation. Fluorescence mi-
croscopy examination of cells attached to coverslips and stained
with Syto19 showed the presence of individual bacteria, small
clusters of cells (microcolonies), and extended areas of the glass
surface covered with large numbers of microcolonies of active cells
(Fig. 2A). B. subtilis BBK006 was able to form biofilms like those
observed for strains of P. aeruginosa and S. epidermidis [37]. In
agreement with previous studies [38,19] we are able to confirm
here that B. subtilis BBK006 biofilm cells are sensitive to some
extent to sophorolipids as seen by the reduction of number of
active cells upon exposure and the appearance of some inactive
reddish-brown fluorescing cells (Fig. 2B). These results indicate
that sophorolipids have the potential to be used for efficient
removal of detrimental biofilms.
It is now generally recognized that biofilms are heterogeneous
structures [39] and that the appearance of specific biofilm func-
tions such as resistance to antimicrobial agents is intimately
related to the inherent three dimensional organizations of cells
and exopolymeric matrix which result from multifactorial pro-
cesses. Bai and co-workers [40] had previously associated bio-
surfactants with an enhanced transport of bacteria through soil
columns, achieved through steric hindrance of the contact
between bacterium and surface and an increase in the negative
surface charge density of the soil. Mireles and co-workers [36]
demonstrated that a range of surfactants (rhamnolipid, surfac-
tin, Tween 80 and sodium dodecyl sulphate) brought about
dissolution of Salmonella enterica biofilms, which reflects the
diversity in the nature and recalcitrance of biofilms produced.
These observations were similar to those reported by Davey and
co-workers [32], although different media, strains and means for
growing biofilms were used, similar conclusions were drawn as
in the present study. However we note that concentrations
evaluated need to be optimized to be considering as a focuscontent (arrows). The magnification for A = 300 mm, B = 100 mm, C and D = 50 mm
images E and F of B. subtilis BBK006 and S. aureus ATCC 9144 (D and F) treated with S
F = 10 mm.point for further scale-up of production and future to biotech-
nological applications. The development of a biofilm mainly
constitutes a survival strategy for bacteria providing a protective
environment safe from stresses such as microbicide action and
can thus lead to significant health-care problems. Using a model
of study for biofilm resistance we used a mixed culture biofilm of
S. aureus ATCC 9144 and B. subtilis BBK006 to test the effects of
sophorolipids.
Understanding the complex way that bacteria (as single or
mixed culture) colonize and build specialized structures like bio-
films and formulating new strategies to deal with their formation
or facilitate their disruption through removal or killing are current
issues in medical and industrial microbiology. One of the possible
solutions for this global problem is the appropriate use of antimi-
crobial combinations [41]. In this report, sophorolipids (S1) at 5%
v/v induced disruption on mature maximal biofilms of B. subtilis
BBK006 and a mixed culture between B. subtilis BBK006 and S.
aureus ATCC 9144. B. subtilis cells treated with sophorolipids were
disrupted with the outpouring of their cytoplasmic contents,
likely due to the release of an intracellular enzyme; malate dehy-
drogenase indicating the interaction of sophorolipids with the
cellular membrane and increased permeability [21]. This is true for
either Gram-positive or mixed cultures, despite the fact that most
bacterial biofilms display resistance against antimicrobials such as
antibiotics and various host immune responses [21]. Sophorolipids
are biologically produced compounds from yeasts strains and are
generally regarded as being biocompatible and safe for human use
while having significant disruption of biofilms produced by differ-
ent microorganisms [42].
Although the mechanism of action of biosurfactants on biofilm
disruption is not well known, a generalized activity of altering
charge-charge properties is hypothesized [32], which may decrease
the chances for bacteria to acquire antibiotic resistance due to
spontaneous mutations. Further studies on the action of different
natural sophorolipids, alone or as adjuvants in combination with
other compounds such as antibiotics or enzymes is of great im-
portance. Such combination may play an important role on the
stability of the EPS during biofilm formation [38,43] which can
lead to new approaches to combat the establishment or disrupt
biofilms formed by different bacterial species. It is also important
to take into account that the combinations treatments may behave
differently for some species.
Conclusions
Sophorolipids were effective as a bactericidal agent regardless of
their acid/lactonic content, able to induce cell death of planktonic
cells of a representative Gram positive and Gram negative bacteria
comparable to conventional antimicrobials which had bacterio-
static effects. Sophorolipids were able as to disrupt biofilms at
concentrations over than 5% (v/v). The results show that sophor-
olipids are promising bactericidal molecules for biomedical tech-
nological applications in industrial systems and need to be studied
in detail at large scale systems and in conjunction with animal
tissue models. and E and F = 10 mm. Note the extracellular matrix encapsulating cells in
1. The magnification for A = 300 mm, B = 100 mm, C and D = 50 mm and E and
www.elsevier.com/locate/nbt 725
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